First Time Loading...
S

Shanghai Haishun New Pharmaceutical Packaging Co Ltd
SZSE:300501

Watchlist Manager
Shanghai Haishun New Pharmaceutical Packaging Co Ltd
SZSE:300501
Watchlist
Price: 12.15 CNY 0.58% Market Closed
Updated: Apr 28, 2024

Income Statement

Earnings Waterfall
Shanghai Haishun New Pharmaceutical Packaging Co Ltd

Revenue
1.1B CNY
Cost of Revenue
-762.6m CNY
Gross Profit
294m CNY
Operating Expenses
-164m CNY
Operating Income
130m CNY
Other Expenses
-19.8m CNY
Net Income
110.2m CNY

Income Statement
Shanghai Haishun New Pharmaceutical Packaging Co Ltd

Rotate your device to view
Income Statement
Currency: CNY
Dec-2015 Mar-2016 Jun-2016 Sep-2016 Dec-2016 Mar-2017 Jun-2017 Sep-2017 Dec-2017 Mar-2018 Jun-2018 Sep-2018 Dec-2018 Mar-2019 Jun-2019 Sep-2019 Dec-2019 Mar-2020 Jun-2020 Sep-2020 Dec-2020 Mar-2021 Jun-2021 Sep-2021 Dec-2021 Mar-2022 Jun-2022 Sep-2022 Dec-2022 Mar-2023 Jun-2023 Sep-2023
Revenue
Revenue
294
N/A
290
-1%
282
-3%
284
+1%
301
+6%
319
+6%
337
+6%
365
+8%
376
+3%
405
+8%
436
+8%
463
+6%
507
+9%
561
+11%
572
+2%
608
+6%
621
+2%
613
-1%
643
+5%
658
+2%
714
+9%
782
+10%
816
+4%
841
+3%
857
+2%
865
+1%
908
+5%
950
+5%
1 013
+7%
1 041
+3%
1 060
+2%
1 057
0%
Gross Profit
Cost of Revenue
(186)
(183)
(175)
(174)
(185)
(198)
(212)
(235)
(236)
(260)
(284)
(307)
(342)
(386)
(397)
(419)
(429)
(427)
(440)
(448)
(472)
(520)
(562)
(591)
(612)
(633)
(661)
(696)
(745)
(766)
(777)
(763)
Gross Profit
108
N/A
106
-1%
107
+1%
110
+3%
116
+5%
121
+4%
125
+3%
130
+4%
140
+8%
145
+4%
153
+5%
157
+3%
165
+5%
175
+6%
174
0%
188
+8%
193
+2%
186
-3%
203
+9%
210
+3%
242
+15%
262
+9%
255
-3%
251
-2%
245
-2%
232
-5%
247
+6%
253
+3%
268
+6%
275
+3%
283
+3%
294
+4%
Operating Income
Operating Expenses
(45)
(41)
(45)
(45)
(50)
(54)
(56)
(62)
(70)
(71)
(81)
(85)
(95)
(105)
(113)
(121)
(129)
(124)
(118)
(107)
(129)
(128)
(129)
(138)
(138)
(133)
(145)
(145)
(155)
(149)
(156)
(164)
Selling, General & Administrative
(26)
(41)
(44)
(44)
(32)
(54)
(48)
(49)
(53)
(70)
(70)
(75)
(69)
(78)
(93)
(102)
(94)
(98)
(98)
(95)
(96)
(104)
(101)
(103)
(98)
(102)
(110)
(109)
(109)
(109)
(114)
(119)
Research & Development
(17)
0
0
0
(16)
0
0
(4)
(17)
0
0
(2)
(22)
(10)
(20)
(22)
(26)
(28)
(24)
(24)
(23)
(26)
(28)
(30)
(32)
(34)
(41)
(43)
(42)
(45)
(45)
(48)
Depreciation & Amortization
(1)
0
0
0
(1)
0
0
0
(2)
0
0
0
(7)
0
0
0
(12)
0
0
0
(12)
0
0
0
(11)
0
0
0
(12)
0
0
0
Other Operating Expenses
(0)
0
0
(1)
(0)
0
(9)
(9)
2
0
(10)
(8)
4
(17)
0
2
2
2
4
12
2
1
1
(6)
3
4
5
7
9
6
4
3
Operating Income
63
N/A
65
+3%
63
-4%
66
+5%
66
+1%
67
+1%
69
+3%
68
-1%
70
+4%
74
+5%
72
-2%
72
-1%
70
-2%
70
+1%
61
-13%
68
+10%
63
-6%
62
-1%
85
+37%
102
+20%
113
+10%
134
+19%
126
-6%
112
-11%
106
-5%
100
-6%
101
+2%
108
+7%
113
+5%
126
+11%
128
+1%
130
+2%
Pre-Tax Income
Interest Income Expense
3
3
3
3
7
8
8
8
6
4
7
9
8
8
5
6
11
8
12
11
7
9
7
5
12
10
13
16
10
(0)
(13)
8
Non-Reccuring Items
0
0
1
0
0
0
0
0
(0)
0
0
(0)
(2)
0
0
(0)
(1)
0
0
0
(0)
0
0
0
(1)
0
(0)
(0)
(1)
(0)
(0)
(0)
Gain/Loss on Disposition of Assets
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Total Other Income
2
1
1
3
1
2
3
3
1
(0)
(1)
(1)
1
0
5
5
(0)
(1)
(7)
(7)
(1)
(1)
(1)
(1)
1
(0)
(0)
0
1
0
0
0
Pre-Tax Income
69
N/A
68
0%
67
-2%
71
+6%
74
+4%
77
+4%
80
+4%
78
-3%
77
-1%
77
+1%
78
+1%
80
+3%
77
-4%
79
+2%
71
-10%
77
+9%
73
-5%
70
-5%
91
+31%
107
+17%
119
+11%
142
+19%
133
-7%
116
-12%
117
+1%
109
-7%
114
+5%
124
+8%
123
-1%
126
+2%
115
-9%
138
+20%
Net Income
Tax Provision
(10)
(9)
(8)
(9)
(9)
(10)
(14)
(13)
(11)
(11)
(10)
(11)
(13)
(13)
(12)
(12)
(7)
(6)
(9)
(13)
(13)
(17)
(15)
(10)
(8)
(7)
(7)
(8)
(13)
(13)
(15)
(18)
Income from Continuing Operations
59
59
59
62
65
66
66
65
66
66
68
70
64
66
59
65
66
64
82
94
105
125
118
106
109
102
107
116
110
113
100
120
Income to Minority Interest
0
0
0
0
(0)
(0)
(0)
(0)
0
0
0
1
2
2
2
1
1
0
(0)
(1)
(3)
(3)
(3)
(3)
(4)
(5)
(6)
(7)
(7)
(9)
(10)
(10)
Net Income (Common)
59
N/A
59
+0%
59
+1%
62
+5%
65
+4%
66
+2%
66
-1%
64
-2%
66
+2%
67
+1%
69
+3%
70
+3%
66
-6%
68
+2%
61
-9%
66
+8%
67
+1%
64
-5%
82
+28%
94
+14%
103
+10%
122
+19%
114
-6%
103
-10%
105
+1%
97
-8%
101
+5%
109
+8%
102
-6%
104
+1%
90
-13%
110
+22%
EPS (Diluted)
0.52
N/A
0.38
-27%
0.39
+3%
0.41
+5%
0.67
+63%
0.65
-3%
0.32
-51%
0.42
+31%
0.43
+2%
0.44
+2%
0.44
N/A
0.46
+5%
0.44
-4%
0.44
N/A
0.4
-9%
0.43
+7%
0.43
N/A
0.4
-7%
0.54
+35%
0.61
+13%
0.66
+8%
0.78
+18%
0.73
-6%
0.53
-27%
0.64
+21%
0.49
-23%
0.52
+6%
0.57
+10%
0.53
-7%
0.54
+2%
0.47
-13%
0.57
+21%

See Also

Discover More